PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23849171-0	2013	Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.	sulfamides	56-66	carbonic anhydrase 9	Homo sapiens	10-31	
23656776-7	2013	Both genetic silencing and pharmacological inhibition of CA IX (with sulfonamide/sulfamides potent inhibitors) or metalloprotease-9 are sufficient to impede epithelial-mesenchymal transition and invasiveness of prostate cancer cells induced by contact with cancer-associated fibroblasts.	sulfamides	81-91	carbonic anhydrase 9	Homo sapiens	57-62	
19679200-9	2010	As all mammalian CAs, CA IX is inhibited by several main classes of inhibitors, such as the inorganic anions, the sulfonamides and their bioisosteres (sulfamates, sulfamides, etc.	sulfamides	163-173	carbonic anhydrase 9	Homo sapiens	22-27	
23199483-4	2013	The search for specific CA IX inhibitors by using the sugar approach has become an important research field, leading to sulfonamides, sulfamates, sulfamides and coumarins with excellent in vitro activity and relevant potency in vivo, in animal models of cancer.	sulfamides	146-156	carbonic anhydrase 9	Homo sapiens	24-29